Heart HealthSimon Hill Reveals His Full Plaque Protocol and Why He Started a PCSK9 Inhibitor
Simon Hill shares the complete cardiovascular protocol behind his widely discussed coronary plaque scans. Three AI platforms analyzed the same images and returned results ranging from a 48% reduction to a 20% increase — a sixfold spread in absolute plaque volume. Hill explains why he anchors to one analysis over the others, informed by cardiologist Dr. Matthew Budoff's guidance on AI overestimation concerns. He walks through his nutrition, training, and sleep habits, the supplements he deliberately skipped, and why cumulative ApoB exposure — not a single cholesterol snapshot — is the metric that drives his decisions. Despite encouraging scan results, Hill ultimately chose to start a PCSK9 inhibitor rather than a statin, citing long-term ApoB burden as his primary rationale. He urges listeners to view short-interval scan results, including his own, with healthy skepticism.
